Cabaletta Bio Inc
Updated September 2020.
100%
Employees say this is a great place to work
Company Overview
About The Company
Cabaletta Bio is focused on the discovery and development of T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T cell products to transform the lives of patients with autoimmune diseases by aiming to deliver deep and durable – potentially curative – responses.
COMPANY SIZE
31 U.S.-based Employees
(Small)
Industry
Biotechnology & Pharmaceuticals
HQ Location
Philadelphia, PA, US
Interested in a career at Cabaletta Bio Inc, or just want to know more?
To discover what sets Cabaletta Bio Inc apart and explore relevant career opportunities, take a look at their website.
Employee Demographics
Generation
Tenure
Company Culture at Cabaletta Bio Inc
The employee experience below at Cabaletta Bio Inc, compared to a typical company.
Learn More100% of employees at Cabaletta Bio Inc say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
100%
Management is approachable, easy to talk with.
100%
People here are given a lot of responsibility.
100%
Management delivers on its promises.
100%
Management's actions match its words.
100%
I believe management would lay people off only as a last resort.
Why Work at Cabaletta Bio Inc?
See what employees say about what makes Cabaletta Bio Inc a great workplace. These words are drawn from employee comments on the Trust Index™ survey.
Best Workplaces Lists
Great Place To Work® is proud to recognize Cabaletta Bio Inc
CONNECT